What was reported
A focused Cas9 screen identified GNPTAB as a regulator of senescence. The assessment describes a noncanonical interaction with STING and a binding-deficient mutant that retained the tested lysosomal functions without inducing senescence. [C01]
What the result does not establish
This is mechanistic human-cell evidence, not treatment of people. Deleting or suppressing GNPTAB everywhere would not follow from an interaction-specific result.
Measured endpoint
Senescence-associated behavior; inflammatory signaling; tested lysosomal functions.
Karam’s next question
Can the unwanted interaction be interrupted while preserving essential maintenance, and does the benefit replicate independently?
Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.
